LFB Biotech Exercise Option to purchase $12.80M in Additional Convertible Shares of Preferred from GTC Biothera (GTCB)

November 2, 2009 9:25 AM EST Send to a Friend
GTC Biotherapeutics, Inc. (NASDAQ: GTCB) announced that LFB Biotechnologies, a strategic shareholder in GTC, has exercised its option to purchase ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login